 | • レポートコード：QYR2104Z4440 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、パーキンソン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ドーパミン作動薬、レボドパ、グルタメート拮抗薬、アポモルヒネ、COMT阻害薬抗コリン作用薬、MAO-B阻害薬、その他）、用途別市場規模（病院、医療機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・パーキンソン病治療の市場動向 ・企業の競争状況、市場シェア ・パーキンソン病治療の種類別市場規模（ドーパミン作動薬、レボドパ、グルタメート拮抗薬、アポモルヒネ、COMT阻害薬抗コリン作用薬、MAO-B阻害薬、その他） ・パーキンソン病治療の用途別市場規模（病院、医療機関、その他） ・パーキンソン病治療の北米市場規模2016-2027（アメリカ、カナダ） ・パーキンソン病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・パーキンソン病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・パーキンソン病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・パーキンソン病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GSK、Merck、Novartis、Teva、Boehringer Ingelheim、Impax、Abbvie、Bausch Health、Lundbeck、Sun Pharma、Wockhardt、Acadia、UCB） ・結論 |
Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.
Market Analysis and Insights: Global Parkinson’s Disease Treatments Market
The global Parkinson’s Disease Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson’s Disease Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parkinson’s Disease Treatments market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parkinson’s Disease Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parkinson’s Disease Treatments market.
Global Parkinson’s Disease Treatments Scope and Market Size
Parkinson’s Disease Treatments market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson’s Disease Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Dopamine Agonists
Levodopa
Glutamate Antagonist
Apomorphine
COMT Inhibitors Anticholinergics
MAO-B Inhibitors
Other Drugs
Segment by Application
Hospitals
Healthcare Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Teva
Boehringer Ingelheim
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson’s Disease Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dopamine Agonists
1.2.3 Levodopa
1.2.4 Glutamate Antagonist
1.2.5 Apomorphine
1.2.6 COMT Inhibitors Anticholinergics
1.2.7 MAO-B Inhibitors
1.2.8 Other Drugs
1.3 Market by Application
1.3.1 Global Parkinson’s Disease Treatments Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Healthcare Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson’s Disease Treatments Market Perspective (2016-2027)
2.2 Parkinson’s Disease Treatments Growth Trends by Regions
2.2.1 Parkinson’s Disease Treatments Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parkinson’s Disease Treatments Historic Market Share by Regions (2016-2021)
2.2.3 Parkinson’s Disease Treatments Forecasted Market Size by Regions (2022-2027)
2.3 Parkinson’s Disease Treatments Industry Dynamic
2.3.1 Parkinson’s Disease Treatments Market Trends
2.3.2 Parkinson’s Disease Treatments Market Drivers
2.3.3 Parkinson’s Disease Treatments Market Challenges
2.3.4 Parkinson’s Disease Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Treatments Players by Revenue
3.1.1 Global Top Parkinson’s Disease Treatments Players by Revenue (2016-2021)
3.1.2 Global Parkinson’s Disease Treatments Revenue Market Share by Players (2016-2021)
3.2 Global Parkinson’s Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson’s Disease Treatments Revenue
3.4 Global Parkinson’s Disease Treatments Market Concentration Ratio
3.4.1 Global Parkinson’s Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatments Revenue in 2020
3.5 Parkinson’s Disease Treatments Key Players Head office and Area Served
3.6 Key Players Parkinson’s Disease Treatments Product Solution and Service
3.7 Date of Enter into Parkinson’s Disease Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson’s Disease Treatments Breakdown Data by Type
4.1 Global Parkinson’s Disease Treatments Historic Market Size by Type (2016-2021)
4.2 Global Parkinson’s Disease Treatments Forecasted Market Size by Type (2022-2027)
5 Parkinson’s Disease Treatments Breakdown Data by Application
5.1 Global Parkinson’s Disease Treatments Historic Market Size by Application (2016-2021)
5.2 Global Parkinson’s Disease Treatments Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Parkinson’s Disease Treatments Market Size (2016-2027)
6.2 North America Parkinson’s Disease Treatments Market Size by Type
6.2.1 North America Parkinson’s Disease Treatments Market Size by Type (2016-2021)
6.2.2 North America Parkinson’s Disease Treatments Market Size by Type (2022-2027)
6.2.3 North America Parkinson’s Disease Treatments Market Size by Type (2016-2027)
6.3 North America Parkinson’s Disease Treatments Market Size by Application
6.3.1 North America Parkinson’s Disease Treatments Market Size by Application (2016-2021)
6.3.2 North America Parkinson’s Disease Treatments Market Size by Application (2022-2027)
6.3.3 North America Parkinson’s Disease Treatments Market Size by Application (2016-2027)
6.4 North America Parkinson’s Disease Treatments Market Size by Country
6.4.1 North America Parkinson’s Disease Treatments Market Size by Country (2016-2021)
6.4.2 North America Parkinson’s Disease Treatments Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Parkinson’s Disease Treatments Market Size (2016-2027)
7.2 Europe Parkinson’s Disease Treatments Market Size by Type
7.2.1 Europe Parkinson’s Disease Treatments Market Size by Type (2016-2021)
7.2.2 Europe Parkinson’s Disease Treatments Market Size by Type (2022-2027)
7.2.3 Europe Parkinson’s Disease Treatments Market Size by Type (2016-2027)
7.3 Europe Parkinson’s Disease Treatments Market Size by Application
7.3.1 Europe Parkinson’s Disease Treatments Market Size by Application (2016-2021)
7.3.2 Europe Parkinson’s Disease Treatments Market Size by Application (2022-2027)
7.3.3 Europe Parkinson’s Disease Treatments Market Size by Application (2016-2027)
7.4 Europe Parkinson’s Disease Treatments Market Size by Country
7.4.1 Europe Parkinson’s Disease Treatments Market Size by Country (2016-2021)
7.4.2 Europe Parkinson’s Disease Treatments Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Parkinson’s Disease Treatments Market Size (2016-2027)
8.2 Asia-Pacific Parkinson’s Disease Treatments Market Size by Type
8.2.1 Asia-Pacific Parkinson’s Disease Treatments Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parkinson’s Disease Treatments Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parkinson’s Disease Treatments Market Size by Type (2016-2027)
8.3 Asia-Pacific Parkinson’s Disease Treatments Market Size by Application
8.3.1 Asia-Pacific Parkinson’s Disease Treatments Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parkinson’s Disease Treatments Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parkinson’s Disease Treatments Market Size by Application (2016-2027)
8.4 Asia-Pacific Parkinson’s Disease Treatments Market Size by Region
8.4.1 Asia-Pacific Parkinson’s Disease Treatments Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parkinson’s Disease Treatments Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Parkinson’s Disease Treatments Market Size (2016-2027)
9.2 Latin America Parkinson’s Disease Treatments Market Size by Type
9.2.1 Latin America Parkinson’s Disease Treatments Market Size by Type (2016-2021)
9.2.2 Latin America Parkinson’s Disease Treatments Market Size by Type (2022-2027)
9.2.3 Latin America Parkinson’s Disease Treatments Market Size by Type (2016-2027)
9.3 Latin America Parkinson’s Disease Treatments Market Size by Application
9.3.1 Latin America Parkinson’s Disease Treatments Market Size by Application (2016-2021)
9.3.2 Latin America Parkinson’s Disease Treatments Market Size by Application (2022-2027)
9.3.3 Latin America Parkinson’s Disease Treatments Market Size by Application (2016-2027)
9.4 Latin America Parkinson’s Disease Treatments Market Size by Country
9.4.1 Latin America Parkinson’s Disease Treatments Market Size by Country (2016-2021)
9.4.2 Latin America Parkinson’s Disease Treatments Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson’s Disease Treatments Market Size (2016-2027)
10.2 Middle East & Africa Parkinson’s Disease Treatments Market Size by Type
10.2.1 Middle East & Africa Parkinson’s Disease Treatments Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parkinson’s Disease Treatments Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parkinson’s Disease Treatments Market Size by Type (2016-2027)
10.3 Middle East & Africa Parkinson’s Disease Treatments Market Size by Application
10.3.1 Middle East & Africa Parkinson’s Disease Treatments Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parkinson’s Disease Treatments Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parkinson’s Disease Treatments Market Size by Application (2016-2027)
10.4 Middle East & Africa Parkinson’s Disease Treatments Market Size by Country
10.4.1 Middle East & Africa Parkinson’s Disease Treatments Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parkinson’s Disease Treatments Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Parkinson’s Disease Treatments Introduction
11.1.4 GSK Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Parkinson’s Disease Treatments Introduction
11.2.4 Merck Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Parkinson’s Disease Treatments Introduction
11.3.4 Novartis Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Parkinson’s Disease Treatments Introduction
11.4.4 Teva Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.4.5 Teva Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson’s Disease Treatments Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Impax
11.6.1 Impax Company Details
11.6.2 Impax Business Overview
11.6.3 Impax Parkinson’s Disease Treatments Introduction
11.6.4 Impax Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.6.5 Impax Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson’s Disease Treatments Introduction
11.7.4 Abbvie Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.7.5 Abbvie Recent Development
11.8 Bausch Health
11.8.1 Bausch Health Company Details
11.8.2 Bausch Health Business Overview
11.8.3 Bausch Health Parkinson’s Disease Treatments Introduction
11.8.4 Bausch Health Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.8.5 Bausch Health Recent Development
11.9 Lundbeck
11.9.1 Lundbeck Company Details
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Parkinson’s Disease Treatments Introduction
11.9.4 Lundbeck Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.9.5 Lundbeck Recent Development
11.10 Sun Pharma
11.10.1 Sun Pharma Company Details
11.10.2 Sun Pharma Business Overview
11.10.3 Sun Pharma Parkinson’s Disease Treatments Introduction
11.10.4 Sun Pharma Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.10.5 Sun Pharma Recent Development
11.11 Wockhardt
11.11.1 Wockhardt Company Details
11.11.2 Wockhardt Business Overview
11.11.3 Wockhardt Parkinson’s Disease Treatments Introduction
11.11.4 Wockhardt Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.11.5 Wockhardt Recent Development
11.12 Acadia
11.12.1 Acadia Company Details
11.12.2 Acadia Business Overview
11.12.3 Acadia Parkinson’s Disease Treatments Introduction
11.12.4 Acadia Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.12.5 Acadia Recent Development
11.13 UCB
11.13.1 UCB Company Details
11.13.2 UCB Business Overview
11.13.3 UCB Parkinson’s Disease Treatments Introduction
11.13.4 UCB Revenue in Parkinson’s Disease Treatments Business (2016-2021)
11.13.5 UCB Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Parkinson's Disease Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dopamine Agonists
Table 3. Key Players of Levodopa
Table 4. Key Players of Glutamate Antagonist
Table 5. Key Players of Apomorphine
Table 6. Key Players of COMT Inhibitors Anticholinergics
Table 7. Key Players of MAO-B Inhibitors
Table 8. Key Players of Other Drugs
Table 9. Global Parkinson's Disease Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Parkinson's Disease Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Parkinson's Disease Treatments Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Parkinson's Disease Treatments Market Share by Regions (2016-2021)
Table 13. Global Parkinson's Disease Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Parkinson's Disease Treatments Market Share by Regions (2022-2027)
Table 15. Parkinson's Disease Treatments Market Trends
Table 16. Parkinson's Disease Treatments Market Drivers
Table 17. Parkinson's Disease Treatments Market Challenges
Table 18. Parkinson's Disease Treatments Market Restraints
Table 19. Global Parkinson's Disease Treatments Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Parkinson's Disease Treatments Market Share by Players (2016-2021)
Table 21. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Treatments as of 2020)
Table 22. Ranking of Global Top Parkinson's Disease Treatments Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Parkinson's Disease Treatments Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Parkinson's Disease Treatments Product Solution and Service
Table 26. Date of Enter into Parkinson's Disease Treatments Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Parkinson's Disease Treatments Revenue Market Share by Type (2016-2021)
Table 30. Global Parkinson's Disease Treatments Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Parkinson's Disease Treatments Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Parkinson's Disease Treatments Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Parkinson's Disease Treatments Revenue Market Share by Application (2016-2021)
Table 34. Global Parkinson's Disease Treatments Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Parkinson's Disease Treatments Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Parkinson's Disease Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Parkinson's Disease Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Parkinson's Disease Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Parkinson's Disease Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Parkinson's Disease Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Parkinson's Disease Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Parkinson's Disease Treatments Product
Table 69. GSK Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Parkinson's Disease Treatments Product
Table 74. Merck Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Parkinson's Disease Treatments Product
Table 79. Novartis Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Teva Company Details
Table 82. Teva Business Overview
Table 83. Teva Parkinson's Disease Treatments Product
Table 84. Teva Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 85. Teva Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Parkinson's Disease Treatments Product
Table 89. Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Impax Company Details
Table 92. Impax Business Overview
Table 93. Impax Parkinson's Disease Treatments Product
Table 94. Impax Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 95. Impax Recent Development
Table 96. Abbvie Company Details
Table 97. Abbvie Business Overview
Table 98. Abbvie Parkinson's Disease Treatments Product
Table 99. Abbvie Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 100. Abbvie Recent Development
Table 101. Bausch Health Company Details
Table 102. Bausch Health Business Overview
Table 103. Bausch Health Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 104. Bausch Health Recent Development
Table 105. Lundbeck Company Details
Table 106. Lundbeck Business Overview
Table 107. Lundbeck Parkinson's Disease Treatments Product
Table 108. Lundbeck Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 109. Lundbeck Recent Development
Table 110. Sun Pharma Company Details
Table 111. Sun Pharma Business Overview
Table 112. Sun Pharma Parkinson's Disease Treatments Product
Table 113. Sun Pharma Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 114. Sun Pharma Recent Development
Table 115. Wockhardt Company Details
Table 116. Wockhardt Business Overview
Table 117. Wockhardt Parkinson's Disease Treatments Product
Table 118. Wockhardt Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 119. Wockhardt Recent Development
Table 120. Acadia Company Details
Table 121. Acadia Business Overview
Table 122. Acadia Parkinson's Disease Treatments Product
Table 123. Acadia Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 124. Acadia Recent Development
Table 125. UCB Company Details
Table 126. UCB Business Overview
Table 127. UCB Parkinson's Disease Treatments Product
Table 128. UCB Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million)
Table 129. UCB Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Treatments Market Share by Type: 2020 VS 2027
Figure 2. Dopamine Agonists Features
Figure 3. Levodopa Features
Figure 4. Glutamate Antagonist Features
Figure 5. Apomorphine Features
Figure 6. COMT Inhibitors Anticholinergics Features
Figure 7. MAO-B Inhibitors Features
Figure 8. Other Drugs Features
Figure 9. Global Parkinson's Disease Treatments Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Healthcare Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Parkinson's Disease Treatments Report Years Considered
Figure 14. Global Parkinson's Disease Treatments Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Parkinson's Disease Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Parkinson's Disease Treatments Market Share by Regions: 2020 VS 2027
Figure 17. Global Parkinson's Disease Treatments Market Share by Regions (2022-2027)
Figure 18. Global Parkinson's Disease Treatments Market Share by Players in 2020
Figure 19. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Treatments as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Parkinson's Disease Treatments Revenue in 2020
Figure 21. Global Parkinson's Disease Treatments Revenue Market Share by Type (2016-2021)
Figure 22. Global Parkinson's Disease Treatments Revenue Market Share by Type (2022-2027)
Figure 23. North America Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Parkinson's Disease Treatments Market Share by Type (2016-2027)
Figure 25. North America Parkinson's Disease Treatments Market Share by Application (2016-2027)
Figure 26. North America Parkinson's Disease Treatments Market Share by Country (2016-2027)
Figure 27. United States Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Parkinson's Disease Treatments Market Share by Type (2016-2027)
Figure 31. Europe Parkinson's Disease Treatments Market Share by Application (2016-2027)
Figure 32. Europe Parkinson's Disease Treatments Market Share by Country (2016-2027)
Figure 33. Germany Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Parkinson's Disease Treatments Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Parkinson's Disease Treatments Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Parkinson's Disease Treatments Market Share by Region (2016-2027)
Figure 43. China Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Parkinson's Disease Treatments Market Share by Type (2016-2027)
Figure 51. Latin America Parkinson's Disease Treatments Market Share by Application (2016-2027)
Figure 52. Latin America Parkinson's Disease Treatments Market Share by Country (2016-2027)
Figure 53. Mexico Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Parkinson's Disease Treatments Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Parkinson's Disease Treatments Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Parkinson's Disease Treatments Market Share by Country (2016-2027)
Figure 59. Turkey Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. GSK Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 65. Teva Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 67. Impax Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 68. Abbvie Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 69. Bausch Health Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 70. Lundbeck Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 71. Sun Pharma Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 72. Wockhardt Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 73. Acadia Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 74. UCB Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed